| Roles of phytoestrogen in the pathophysiology of intracranial aneurysm K Yokosuka, C Rutledge, Y Kamio, A Kuwabara, H Sato, R Rahmani, ... Stroke 52 (8), 2661-2670, 2021 | 10 | 2021 |
| Social support programme for tuberculosis patients in Armenia: perceptions of patients and doctors K Davtyan, S Aghabekyan, H Davtyan, T Margaryan, R Zachariah, ... Public Health Panorama 1 (01), 252-259, 2015 | 9 | 2015 |
| Protein precipitation method for determination of clobazam and N‐desmethylclobazam in human plasma by LC–MS/MS A Mikayelyan, A Aleksanyan, M Sargsyan, A Gevorgyan, H Zakaryan, ... Biomedical Chromatography 34 (1), e4710, 2020 | 8 | 2020 |
| High‐throughput protein precipitation method with 96‐well plate for determination of doxepin and nordoxepin in human plasma using LC–MS/MS T Margaryan, M Sargsyan, A Gevorgyan, H Zakaryan, A Aleksanyan, ... Biomedical Chromatography 34 (8), e4844, 2020 | 6 | 2020 |
| Simultaneous determination of LY3214996, abemaciclib, and M2 and M20 metabolites in human plasma, cerebrospinal fluid, and brain tumor by LC-MS/MS T Margaryan, M Elliott, N Sanai, A Tovmasyan Journal of pharmaceutical analysis 12 (4), 601-609, 2022 | 5 | 2022 |
| CTNI-13. A FIRST-IN-HUMAN PHASE 0/1 TRIAL OF 5-AMINOLEVULINIC ACID SONODYNAMIC THERAPY (5-ALA SDT) IN RECURRENT GLIOBLASTOMA N Sanai, AC Tien, A Tovmasyan, YW Chang, T Margaryan, K Hendrickson, ... Neuro-Oncology 24 (Supplement_7), vii72-vii73, 2022 | 4 | 2022 |
| Simultaneous determination of Triamterene and Hydrochlorothiazide in human plasma by liquid chromatography tandem mass spectrometry and its application to a bioequivalence study T Margaryan, A Mikayelyan, H Zakaryan, Y Armoudjian, H Alaverdyan SN Applied Sciences 1 (6), 653, 2019 | 4 | 2019 |
| Folic Acid Improves Parkin-Null Drosophila Phenotypes and Transiently Reduces Vulnerable Dopaminergic Neuron Mitochondrial Hydrogen Peroxide Levels and … KL Houlihan, PP Keoseyan, AN Juba, T Margaryan, ME Voss, ... Antioxidants 11 (10), 2068, 2022 | 3 | 2022 |
| CTNI-48. A PHASE 0 ‘TRIGGER’TRIAL OF CDK4/6 PLUS ERK1/2 INHIBITORS IN RECURRENT GLIOBLASTOMA N Sanai, YW Chang, T Margaryan, A DeSantis, M Elliott, ... Neuro-Oncology 23 (Supplement_6), vi70-vi71, 2021 | 3 | 2021 |
| Effects of β-amyloid (1-42) Administration on the Main Neurogenic Niches of the Adult Brain: Amyloid-Induced Neurodegeneration Influences Neurogenesis K Yenkoyan, T Margaryan, S Matinyan, V Chavushyan, M Danielyan, ... International Journal of Molecular Sciences 23 (23), 15444, 2022 | 2 | 2022 |
| CTNI-14. A PHASE 0 ‘TRIGGER’TRIAL OF NIRAPARIB IN NEWLY-DIAGNOSED GLIOBLASTOMA PATIENTS N Sanai, T Margaryan, J Molloy, W Knight, J Harmon, A Hong, J Wanebo, ... Neuro-oncology 24 (Suppl 7), vii73, 2022 | 2 | 2022 |
| CTNI-23. A FIRST-IN-HUMAN PHASE 0/1 CLINICAL TRIAL OF 5-AMINOLEVULINIC ACID SONODYNAMIC THERAPY IN RECURRENT GLIOBLASTOMA N Sanai, AC Tien, A Tovmasyan, YW Chang, T Margaryan, K Hendrickson, ... Neuro-Oncology 23 (Supplement_6), vi64-vi64, 2021 | 2 | 2021 |
| 505MO A phase 0/Ib study of AZD1390 plus radiotherapy in recurrent glioblastoma patients N Sanai, S Desai, T Margaryan, CL Cascio, M Elliott, J Molloy, J Harmon, ... Annals of Oncology 34, S394, 2023 | 1 | 2023 |
| A phase 0 pharmacokinetic trigger trial of infigratinib in patients with recurrent high-grade glioma. N Sanai, T Margaryan, J Molloy, A DeSantis, J Harmon, A Hong, K Braun, ... Journal of Clinical Oncology 41 (16_suppl), 2051-2051, 2023 | 1 | 2023 |
| A phase 0/2 trigger trial of niraparib in patients with newly diagnosed glioblastoma. S Mehta, N Sanai, T Margaryan, J Molloy, H Zhang, W Knight, J Harmon, ... Journal of Clinical Oncology 41 (16_suppl), 2069-2069, 2023 | 1 | 2023 |
| EXTH-09. TUMOR PHARMACOKINETICS, PHARMACODYNAMICS AND RADIATION SENSITIZATION IN PATIENT-DERIVED XENOGRAFT MODELS OF GLIOBLASTOMA TREATED WITH THE AURORA KINASE A INHIBITOR … S Mehta, A Tovmasyan, AC Tien, M Holter, B Hopkins, T Margaryan, ... Neuro-Oncology 23 (Supplement_6), vi165-vi165, 2021 | 1 | 2021 |
| A validated LC-MS/MS method for determination of neuro-pharmacokinetic behavior of niraparib in brain tumor patients W Knight, T Margaryan, N Sanai, A Tovmasyan Journal of Pharmaceutical and Biomedical Analysis, 116150, 2024 | | 2024 |
| Abstract CT044: A phase 0/1b study of AZD1390 plus radiotherapy in newly-diagnosed, MGMT-unmethylated glioblastoma patients N Sanai, S Desai, T Margaryan, J Molloy, C LoCascio, M Elliott, J Harmon, ... Cancer Research 84 (7_Supplement), CT044-CT044, 2024 | | 2024 |
| Tumor pharmacokinetics and pharmacodynamics assessment of TEAD inhibitor VT03989 in patient-derived xenograft models of glioblastoma T Margaryan, YW Chang, J Molloy, B Hopkins, M Elliott, EL Melendez, ... Cancer Research 84 (6_Supplement), 1660-1660, 2024 | | 2024 |
| Pharmacokinetics assessment of intranasal NEO100 treatment on blood-brain barrier disruption and brain penetration of drugs in rodent brain AT Shivanna, T Margaryan, M Stavnichuk, W Knight, S Patel, E Cabrales, ... Cancer Research 84 (6_Supplement), 7163-7163, 2024 | | 2024 |
